RNDr. Pavel Krejčí, Ph.D.
Head of the research group, Pavel Krejčí Research Group
Office: bldg. A19/231a
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 5395 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 123
2020
-
Thermostable FGF2 Polypeptide, Use Thereof
Publisher: European Patent Office, state: Germany, patent's number: EP3380508, year: 2020
2019
-
C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia
New England Journal of Medicine, year: 2019, volume: 381, edition: 13, DOI
-
Deficiency of Sprouty Proteins in Mice Resemble Ciliopathic Phenotype
Year: 2019, type: Conference abstract
-
Fibroblast growth factor receptor influences primary cilium length through an interaction with intestinal cell kinase
Proceedings of the National Academy of Sciences of the United States of America, year: 2019, volume: 116, edition: 10, DOI
2018
-
Colicin F-Y inhibits pathogenic Yersinia enterocolitica in mice
Scientific reports, year: 2018, volume: 8, edition: 12242, DOI
-
Computer-assisted engineering of hyperstable fibroblast growth factor 2
Biotechnology and Bioengineering, year: 2018, volume: 115, edition: 4, DOI
-
Inhibition of SHIP2 activity inhibits cell migration and could prevent metastasis in breast cancer cells
Journal of Cell Science, year: 2018, volume: 131, edition: 16, DOI
-
Nanodiamonds as "artificial proteins": Regulation of a cell signalling system using low nanomolar solutions of inorganic nanocrystals
Biomaterials, year: 2018, volume: 176, edition: SEP 2018, DOI
-
Proteomic analyses of signalling complexes associated with receptor tyrosine kinase identify novel members of fibroblast growth factor receptor 3 interactome
Cellular Signalling, year: 2018, volume: 42, edition: JAN 2018, DOI
-
Registr Achondroplasie na Slovensku a v České republice
Year: 2018, type: